Achyut Healthcare Ltd vs Jfl Life Sciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Achyut Healthcare Ltd is ₹ 4.97 as of 18 May 14:09 . The P/E Ratio of Achyut Healthcare Ltd changed from 342.5 on March 2022 to 163 on March 2025 . This represents a CAGR of -16.94% over 4 yearsThe P/E Ratio of JFL Life Sciences Ltd changed from 12.9 on March 2023 to 13.9 on March 2025 . This represents a CAGR of 2.52% over 3 years The Market Cap of Achyut Healthcare Ltd changed from ₹ 13.85 crore on March 2022 to ₹ 76.79 crore on March 2025 . This represents a CAGR of 53.45% over 4 yearsThe Market Cap of JFL Life Sciences Ltd changed from ₹ 36.29 crore on March 2023 to ₹ 57.58 crore on March 2025 . This represents a CAGR of 16.63% over 3 years The revenue of Achyut Healthcare Ltd for the Dec '25 is ₹ 1.61 crore as compare to the Sep '25 revenue of ₹ 2.66 crore. This represent the decline of -39.47% The revenue of JFL Life Sciences Ltd for the Dec '25 is ₹ 26.85 crore as compare to the Sep '25 revenue of ₹ 29.92 crore. This represent the decline of -10.26% The ebitda of Achyut Healthcare Ltd for the Dec '25 is ₹ 0.04 crore as compare to the Sep '25 ebitda of ₹ 0.19 crore. This represent the decline of -78.95% The ebitda of JFL Life Sciences Ltd for the Dec '25 is ₹ 3.36 crore as compare to the Sep '25 ebitda of ₹ 2.93 crore. This represent the growth of 14.68% The net profit of Achyut Healthcare Ltd changed from ₹ 0.03 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The net profit of JFL Life Sciences Ltd changed from ₹ 0.74 crore to ₹ 2.02 crore over 7 quarters. This represents a CAGR of 77.51% The Dividend Payout of Achyut Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of JFL Life Sciences Ltd changed from 8.33 % on March 2024 to 0 % on March 2025 . This represents a CAGR of -100.00% over 2 years .

About Achyut Healthcare Ltd

Achyut Healthcare Limited was incorporated as Achyut Securities Private Limited' on January 11, 1996 as a Private Limited Company under the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Haveli.
The Company name was changed to Achyut Healthcare Private Limited', and a fresh Certificate of Incorporation dated November 26, 2002.
Subsequently, the Company got converted from a Private Limited to Public Limited and the name of the Company changed to Achyut Healthcare Limited', and a fresh Certificate of Incorporation dated November 30, 2021 was issued to the Company by Registrar of Companies, Gujarat at Ahmedabad. The Company is engaged in trading of Cenzure, Arpimune, Azathioprine IP, Everolimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium carbonate oyster, Cellulose acetate Phthalate, Chlorthalidone IP, Croscarmellose Sodium IP/USP, DIBasic Calcium Phosphate IP, DIEthyl Phthalate, Diltiazem Hydrochloride IP, Easy Coat Fc Titanium Dioxide, Escitalopram IP, Escitalopram Oxalate, Favipiravir among many other products.

About JFL Life Sciences Ltd

JFL Life Sciences Limited was incorporated as JFL Life Sciences Private Limited' on April 25, 2010 as a Private Limited Company.
Pursuant to a Special Resolution held on February 10, 2022, Company converted from a Private Limited to Public Limited Company and name of the Company was changed to JFL Life Sciences Limited', on March 3, 2022.
The Company manufactures and market pharmaceutical products.
The major products are Dry powder injections, Tablets & Capsules (B-Lactam) solid oral dosage form, Tablet and capsules (General) and Oral Rehydration Solutions (ORS). In August 2022, the Company launched an IPO of 29,78,000 Equity Shares by raising funds aggregating to Rs. 18.16 Crore. The Company export products to African countries, Middle Eastern countries and CIS countries, mainly through merchant exporters.

FAQs for the comparison of Achyut Healthcare Ltd and JFL Life Sciences Ltd

Which company has a larger market capitalization, Achyut Healthcare Ltd or JFL Life Sciences Ltd?

Market cap of Achyut Healthcare Ltd is 116 Cr while Market cap of JFL Life Sciences Ltd is 60 Cr

What are the key factors driving the stock performance of Achyut Healthcare Ltd and JFL Life Sciences Ltd?

The stock performance of Achyut Healthcare Ltd and JFL Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Achyut Healthcare Ltd and JFL Life Sciences Ltd?

As of May 18, 2026, the Achyut Healthcare Ltd stock price is INR ₹4.93. On the other hand, JFL Life Sciences Ltd stock price is INR ₹9.15.

How do dividend payouts of Achyut Healthcare Ltd and JFL Life Sciences Ltd compare?

To compare the dividend payouts of Achyut Healthcare Ltd and JFL Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.